These reports indicate that the over-activated ASK1-MKK4/7-JNK signaling axis plays a critical role in the pathogenesis of MS; that is, deregulated JNK signaling contributes to MS progression [134,135,137]. Here, MAP2K4 is linked to myeloid sarcoma.